Javascript must be enabled to continue!
ISCHEMIA MODIFIED ALBUMIN LEVELS AND INCREASED OXIDATIVE STRESS IN PATIENTS WITH MULTIPLE MYELOMA / NIVOI ALBUMINA MODIFIKOVANOG ISHEMIJOM I POVI[ENI OKSIDANTNI STRES KOD PACIJENATA SA MULTIPLIM MIJELOMOM
View through CrossRef
Summary
Background: Impaired oxidative/antioxidative balance plays an important role in the pathogenesis of many diseases, including cancer. The aim of this study was to evaluate the levels of the novel marker ischemia modified albumin (IMA) and albumin adjusted-IMA (Adj-IMA) in patients with multi- ple myeloma (MM) as well as its association with total antiox- idant status (TAS), total oxidant status (TOS) and oxidative stress index (OSI).
Methods: Forty patients with MM (18 females, 22 males; mean age 67.55±8.39 years) and forty age/sex-matched healthy persons (19 females, 21 males; mean age 66.37 ± 6.76 years) were included in this study. Serum levels of IMA, TAS, TOS were analyzed and Adj-IMA and OSI was calcu- lated. Results:
Serum IMA, TOS and OSI levels were significantly higher in patients with MM compared to controls (p<0.001 all parameters). There was no significant difference for serum albumin-adjusted IMA and TAS levels between groups (p=0.83 and p=0.17 respectively).
Conclusions: In this study, an impaired oxidative/antioxidant status in favor of oxidative stress was found in MM patients. This observation was not confirmed by Adj-IMA calculation. Further studies are needed to establish the relationship of IMA and oxidative stress parameters in multiple myeloma and their relationship to MM and other cancers.
Centre for Evaluation in Education and Science (CEON/CEES)
Title: ISCHEMIA MODIFIED ALBUMIN LEVELS AND INCREASED OXIDATIVE STRESS IN PATIENTS WITH MULTIPLE MYELOMA / NIVOI ALBUMINA MODIFIKOVANOG ISHEMIJOM I POVI[ENI OKSIDANTNI STRES KOD PACIJENATA SA MULTIPLIM MIJELOMOM
Description:
Summary
Background: Impaired oxidative/antioxidative balance plays an important role in the pathogenesis of many diseases, including cancer.
The aim of this study was to evaluate the levels of the novel marker ischemia modified albumin (IMA) and albumin adjusted-IMA (Adj-IMA) in patients with multi- ple myeloma (MM) as well as its association with total antiox- idant status (TAS), total oxidant status (TOS) and oxidative stress index (OSI).
Methods: Forty patients with MM (18 females, 22 males; mean age 67.
55±8.
39 years) and forty age/sex-matched healthy persons (19 females, 21 males; mean age 66.
37 ± 6.
76 years) were included in this study.
Serum levels of IMA, TAS, TOS were analyzed and Adj-IMA and OSI was calcu- lated.
Results:
Serum IMA, TOS and OSI levels were significantly higher in patients with MM compared to controls (p<0.
001 all parameters).
There was no significant difference for serum albumin-adjusted IMA and TAS levels between groups (p=0.
83 and p=0.
17 respectively).
Conclusions: In this study, an impaired oxidative/antioxidant status in favor of oxidative stress was found in MM patients.
This observation was not confirmed by Adj-IMA calculation.
Further studies are needed to establish the relationship of IMA and oxidative stress parameters in multiple myeloma and their relationship to MM and other cancers.
Related Results
Praćenje interfrakcijskog pomjeranja markirane prostate pomoću automatskog zadržavanja snopa
Praćenje interfrakcijskog pomjeranja markirane prostate pomoću automatskog zadržavanja snopa
Uvod: Prema podacima registra za rak u Sloveniji 2018 godine, rak prostate nalazi se na prvom mjestu sa 21% slučajeva. U periodu od 2014 – 2018, prosječna godišnja incidenca raka p...
Alkoholizam kod mladih
Alkoholizam kod mladih
Uvod: Konzumiranje alkohola kod mladih ponašanje je na koje je potrebno obratiti značajnu pozornost, posebice zbog posljedica koje može imati u životu mlade osobe.
Cilj istraživanj...
Study of Ischemia Modified Albumin as New Potential Diagnostic Biomarker In Acute Myocardial Infarction.
Study of Ischemia Modified Albumin as New Potential Diagnostic Biomarker In Acute Myocardial Infarction.
Background: Because of the varied presentation and associated high mortality the identification of patients with acute myocardial infarction is very critical for the patient manage...
MAF Protein Elicits Innate Resistance To Bortezomib In Multiple Myeloma
MAF Protein Elicits Innate Resistance To Bortezomib In Multiple Myeloma
Abstract
Multiple myeloma (MM) is a malignancy of terminally differentiated clonal plasma cells displaying significant molecular heterogeneity with 7 subgroups defin...
Plasma Cell Disorders
Plasma Cell Disorders
Multiple myeloma represents 1.4% of all new patients with cancer and will result in an estimated 11,090 deaths in 2014. It is twice as common in black men as in white men and 2.5 t...
Plasma Cell Disorders
Plasma Cell Disorders
Multiple myeloma represents 1.4% of all new patients with cancer and will result in an estimated 11,090 deaths in 2014. It is twice as common in black men as in white men and 2.5 t...
Data from Functional B7.2 and B7-H2 Molecules on Myeloma Cells Are Associated with a Growth Advantage
Data from Functional B7.2 and B7-H2 Molecules on Myeloma Cells Are Associated with a Growth Advantage
<div>Abstract<p><b>Purpose:</b> B7 family molecules expressed on antigen-presenting cells stimulate or inhibit normal immune responses. The aim of this stud...
Data from Functional B7.2 and B7-H2 Molecules on Myeloma Cells Are Associated with a Growth Advantage
Data from Functional B7.2 and B7-H2 Molecules on Myeloma Cells Are Associated with a Growth Advantage
<div>Abstract<p><b>Purpose:</b> B7 family molecules expressed on antigen-presenting cells stimulate or inhibit normal immune responses. The aim of this stud...

